South Korea pushes back planned lifting of COVID-19 isolation order

입력 2022. 5. 20. 13:19 수정 2022. 5. 20. 13:21
글자크기 설정 파란원을 좌우로 움직이시면 글자크기가 변경 됩니다.

이 글자크기로 변경됩니다.

(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.

Timeline set by Moon admin delayed
Health care worker at a testing center in Jung-gu, central Seoul, prepares for nasal swab tests on Thursday. (Yonhap)

South Korea said Friday the seven-day isolation requirement for people with COVID-19 will remain in place for the next four weeks, until June 20.

Expiring on Sunday is the four-week “probation period” for downgrading COVID-19’s threat status. Last month, the Moon Jae-in administration changed the classification of COVID-19 so that it would no longer be considered an infectious disease with the “highest level of public health hazard.”

The downgrade relieves people confirmed with COVID-19 of the responsibility to self-isolate. But it also means the end of government coverage of COVID-19 medical costs for those in isolation.

In an announcement Friday, health officials said while the omicron wave had stabilized, the discovery of potentially immune-evading, highly transmissible subvariants of omicron continued to pose a threat.

The Korea Disease Control and Prevention Agency said in its weekly report updated Tuesday that at least one case of BA.4 and two cases of BA.5 -- two omicron subvariants being monitored by the World Health Organization -- have been detected.

The BA.4 patient had recently traveled from South Africa. One of the two BA.5 patients had traveled from Turkey. The other was a resident in Incheon with no recent travel history, indicating a possible community transmission.

From May 13 to 18, Korea logged 195,329 cases and 41 deaths per day on average, down from 256,685 cases and 56 deaths seen a week ago. The cumulative counts of total cases and deaths stand at 17,914,957 and 23,885, respectively, putting the case fatality rate at 0.13 percent.  

By Kim Arin (


Copyrightⓒ Herald Media INC. All rights reserved.

이 기사에 대해 어떻게 생각하시나요?